Overview

A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if it is safe and effective to give Viracept to AIDS patients who are already being treated for cytomegalovirus (CMV) retinitis.
Phase:
Phase 2
Details
Lead Sponsor:
Agouron Pharmaceuticals
Treatments:
Nelfinavir